Evans blue nanocarriers visually demarcate margins of invasive gliomas.

about

Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier Agents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical results.Evans Blue Dye: A Revisit of Its Applications in Biomedicine.

P2860

Q28071873-A1568EE0-9472-4E4E-8369-15310EA5A5D5 Q37525571-DD4DBF9F-B625-4C9F-BD7F-92045EC175F9 Q55274518-E2AF9B78-67C3-4833-8E4B-7524E99C066E

P2860

Evans blue nanocarriers visually demarcate margins of invasive gliomas.

Item

http://www.wikidata.org/entity/Q38897823

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Evans blue nanocarriers visually demarcate margins of invasive gliomas.

@en

type

Item

label

Evans blue nanocarriers visually demarcate margins of invasive gliomas.

@en

prefLabel

Evans blue nanocarriers visually demarcate margins of invasive gliomas.

@en

P1476

Evans blue nanocarriers visually demarcate margins of invasive gliomas.

@en

P2093

Barunashish Brahma

http://www.w3.org/2001/XMLSchema#string

Benjamin T Roller

http://www.w3.org/2001/XMLSchema#string

Philip J Santangelo

http://www.w3.org/2001/XMLSchema#string

Ravi V Bellamkonda

http://www.w3.org/2001/XMLSchema#string

S Balakrishna Pai

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci

The brain tumor window model: a combined cranial window and implanted glioma model for evaluating intraoperative contrast agents.

Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers.

Recent advances in therapy for glioblastoma.

Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival.

Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.

A nanoparticle size series for in vivo fluorescence imaging.

Targeted downregulation of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase significantly mitigates chondroitin sulfate proteoglycan-mediated inhibition.

Microsurgery for malignant gliomas.

P2888

s13346-013-0139-x

P304

116-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13346-013-0139-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer M Munson

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1042830901

http://www.w3.org/2001/XMLSchema#string

P698

25787737

http://www.w3.org/2001/XMLSchema#string

P921

nanocarrier

Evans blue

Evans blue nanocarriers visually demarcate margins of invasive gliomas.

about

P2860

P2860

Evans blue nanocarriers visually demarcate margins of invasive gliomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921